Michael S. Aberman, VP Strategy and Investor Relat at REGENERON PHARMACEUTICALS INC (REGN), sold 8,334 shares at $257.29 ($2.1M) on 2013-05-06, disclosed to the SEC on 2013-05-08.
Open-market sale of $2.1M REGN by VP Strategy and Investor Relat. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $256.46 | 1,600 | $410K | 19.1% |
| 2 | $257.29 | 6,734 | $1.7M | 80.9% |
| Total | $257.13 avg | 8,334 | $2.1M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |